| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $193M | — | $139M | — | 38.7% |
| Op. Income | $34M | — | $33M | — | 3.3% |
| Gross Margin | 58.2% | — | 66.0% | — | -7.8pp |
| Net Margin | 14.6% | — | 19.2% | — | -4.6pp |
| EPS (Diluted) | $2.01 | — | $3.25 | — | -38.2% |
| Free Cash Flow | $24M | — | $47M | — | -49.1% |
| Item | Amount |
|---|---|
| REVENUE | $193M |
| Cost of Revenue | $81M |
| GROSS PROFIT | $112M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $62M |
| SG&A Expenses | $62M |
| Other Expenses | $16M |
| Operating Expenses | $78M |
| Cost & Expenses | $159M |
| OPERATING INCOME | $34M |
| Interest Income | $203M |
| Interest Expense | $66M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $34M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $28M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $28M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $28M |
| D&A | $0 |
| EBIT | $34M |
| EBITDA | $34M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $193M |
| Cost of Revenue | $81M |
| GROSS PROFIT | $112M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $62M |
| SG&A Expenses | $62M |
| Other Expenses | $16M |
| Operating Expenses | $78M |
| Cost & Expenses | $159M |
| OPERATING INCOME | $34M |
| Interest Income | $203M |
| Interest Expense | $66M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $34M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $28M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $28M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $28M |
| D&A | $0 |
| EBIT | $34M |
| EBITDA | $34M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $28M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $8M |
| Change in Working Capital | -$15M |
| OPERATING CASH FLOW | $21M |
| Capital Expenditure | -$7M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$29M |
| NET CASH FROM INVESTING | -$29M |
| Net Debt Issuance | -$80M |
| Common Stock Repurchased | -$3M |
| Common Dividends Paid | -$17M |
| Other Financing Activities | $2M |
| NET CASH FROM FINANCING | -$97M |
| FREE CASH FLOW | $24M |
| Net Change in Cash | -$97M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $88M |
| Short-Term Investments | $554M |
| Net Receivables | $11M |
| Inventory | $0 |
| Other Current Assets | -$11M |
| TOTAL CURRENT ASSETS | $642M |
| PP&E (Net) | $48M |
| Goodwill | $130M |
| Intangible Assets | $31M |
| Long-Term Investments | $3.8B |
| Tax Assets | $0 |
| Other Non-Current Assets | -$3.8B |
| TOTAL NON-CURRENT ASSETS | $209M |
| TOTAL ASSETS | $4.4B |
| Account Payables | $0 |
| Short-Term Debt | $246M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $246M |
| Long-Term Debt | $68M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $15M |
| Other Non-Current Liabilities | $3.6B |
| TOTAL NON-CURRENT LIABILITIES | $3.7B |
| TOTAL LIABILITIES | $3.9B |
| Common Stock | $398M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $103M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$36M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $465M |
| Minority Interest | $0 |
| TOTAL EQUITY | $465M |
| TOTAL LIABILITIES & EQUITY | $4.4B |
| Total Debt | $316M |
| Net Debt | $228M |
